Updated: Jun 17, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Jon A Erickson1, Mary M Mader, Ian A Watson
1Eli Lilly and Company, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA. jae@lilly.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study introduces a novel de novo design process for creating kinase inhibitor libraries using quantitative structure-activity relationship (QSAR) models and fragment-based drug design (FBDD) principles. The validated process successfully generated seven new libraries with a 92% hit rate against six kinases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: